Browse the evidence

Early Time-Restricted Eating (eTRE) with an 8-hour window (8 am - 4 pm) does NOT produce significantly greater weight loss than a calorie-restricted Mediterranean diet (MedDiet) in adults with obesity.

Early time-restricted eating (8 am - 4 pm) with a 600-calorie deficit did not result in significantly greater weight loss than a standard Mediterranean diet in this study. You may not see extra benefits from this specific timing strategy.

Loss of the oxygen sensor PHD1 reduces muscle mass by impairing the stability of the leucine sensor LRS, thereby blunting mTORC1 activation specifically in response to leucine.

Maintaining healthy cellular oxygen sensing and nutrient sensor stability (specifically PHD1 and LRS) is crucial for your muscles to respond to protein/leucine intake. This mechanism explains why older adults often experience 'anabolic resistance'—their muscles struggle to build mass from protein because these specific sensors degrade. While you cannot directly 'dose' PHD1, ensuring adequate oxygenation and avoiding chronic metabolic stress may help preserve these sensors.

Dietary supplements are generally safe and pose significantly lower risks of adverse events, hospitalizations, and fatalities compared to prescription drugs and even common foods.

You do not need to fear that taking a standard dietary supplement will cause you to end up in the emergency room or suffer a fatal outcome. The data shows that serious adverse events from supplements are extremely rare compared to prescription medications and even foodborne illnesses. However, you should still choose products from reputable manufacturers that undergo third-party testing (like NSF or Informed Choice) to ensure purity and avoid adulterated products.

Chronic low-grade inflammation, driven by obesity and ectopic lipid deposition, impairs insulin signaling and beta-cell function through pathways like NF-κB, JNK, and oxidative stress.

Inflammation is not just a symptom of diabetes; it is a cause. Excess fat, especially around organs (ectopic fat), triggers inflammation that blocks insulin from working and damages insulin-producing cells. Managing weight and diet reduces this inflammation.

Type 2 diabetes negates the natural cardiovascular protection typically afforded to premenopausal women, resulting in a 25–50% greater excess risk of incident cardiovascular disease in women compared to men with diabetes.

If you have type 2 diabetes, your risk of heart disease is not lower than a man's, even if you are a woman. Diabetes removes the natural heart protection women usually have. You need to manage blood pressure, lipids, and blood sugar as aggressively as a man would to protect your heart.

Females have higher rates of insulin resistance than males from early childhood through mid-puberty, whereas males exhibit greater insulin resistance during late puberty and adulthood.

Insulin resistance changes differently for boys and girls as they grow. Girls tend to be more insulin resistant during early puberty, while boys become more resistant later. This biological difference contributes to why girls are more prone to type 2 diabetes in youth, while men are more prone in midlife.

A high Triglyceride-Glucose (TyG) index is positively associated with a higher prevalence of symptomatic coronary artery disease (CAD) in secondary care patients, independent of social, clinical, and behavioral risk factors.

If you are in secondary cardiac care, ask your doctor about your Triglyceride-Glucose (TyG) index. It is a calculated marker of insulin resistance derived from your fasting triglycerides and glucose levels. A high TyG index is a strong predictor of symptomatic heart disease, even if your standard cholesterol numbers look acceptable. Managing this index through lifestyle changes (diet and activity) is crucial for reducing cardiac risk.

Global dietary quality, measured by the Alternative Healthy Eating Index (AHEI), is modest (mean score 40.3/100) and has improved only slightly (+1.5 points) globally between 1990 and 2018, with significant regional disparities where South Asia and Sub-Saharan Africa saw no improvement or decline.

Your overall diet matters more than any single food. Globally, average diet quality is low (40/100). To improve, focus on increasing fruits, vegetables, whole grains, and healthy fats while reducing sugar-sweetened beverages, red/processed meat, and sodium. This applies to everyone, but the specific gaps vary by region and education level. In many areas, simply increasing produce intake yields the biggest health return.

Macroscopic increases in muscle size (hypertrophy) do not necessarily reflect proportional increases in contractile (myofibrillar) protein; instead, they often result from sarcoplasmic expansion (fluid, glycogen, non-contractile proteins), leading to a dilution of myofibrillar protein concentration.

When you see muscle size increase, do not automatically assume it is all 'quality' contractile tissue. A significant portion of early or even chronic hypertrophy can be 'sarcoplasmic'—driven by fluid, glycogen, and non-contractile proteins. This means your strength-to-size ratio might not improve as much as your tape measure suggests. Focus on strength metrics and protein synthesis markers, not just visual size, to gauge true contractile adaptation.

Ketogenic diets increase LDL cholesterol and total cholesterol, which may accelerate atherosclerosis and increase cardiovascular disease risk, despite improving triglycerides and HDL.

Monitor your LDL cholesterol closely when starting a ketogenic diet. While your triglycerides may drop and HDL rise, your LDL may increase significantly. If you have a history of cardiovascular disease or high baseline LDL, consult your provider, as this increase may pose a risk. Consider shifting fat sources to plant-based options (nuts, vegetables) to potentially mitigate LDL elevation.

GIP promotes lipogenesis (fat storage) in adipose tissue, while GLP-1 promotes lipolysis (fat breakdown) indirectly via sympathetic nervous system activation.

GIP helps store fat in adipose tissue, while GLP-1 helps break it down. Dual agonists balance these effects to improve overall metabolic health.

Menstrual cycle phase does not appreciably influence acute strength performance or chronic adaptations (strength/hypertrophy) to resistance exercise training in naturally cycling women.

Do not restrict your training volume, intensity, or frequency based on your menstrual cycle phase. The current scientific consensus indicates that hormonal fluctuations across the cycle do not significantly impact your ability to build strength or muscle. Focus on consistent, high-quality resistance training regardless of where you are in your cycle. If you experience menstrual symptoms that affect your well-being, adjust for comfort, not for perceived biological incapacity.

Weight stigma and discrimination are significant behavioral and emotional mechanisms linking high body weight to psychological distress.

Recognize that weight stigma is a real and harmful social force, not a personal failing. Seek supportive environments and mental health resources that address the impact of discrimination.

Systemic inflammation and HPA-axis dysregulation are biological mechanisms mediating the link between high body weight and psychological distress.

Understand that biological factors like inflammation and stress hormone dysregulation contribute to the link between obesity and depression. This is not just 'in your head' but has a physical basis.

Individuals with Medicare, dual-eligible insurance, lower education, older age, and male sex bear the highest annual diet-related CMD costs.

Targeted interventions for older adults, men, those with lower education, and those with public insurance (Medicare/dual-eligible) could yield significant cost savings. Focus on increasing nuts, seeds, and seafood omega-3s, and reducing processed meats, sodium, and SSBs.

Global sugar-sweetened beverage (SSB) intake among adults increased by 16% (0.37 servings/week) between 1990 and 2018, with the most dramatic increases occurring in Sub-Saharan Africa (+81.9%) and specific high-population countries like Nigeria and Ethiopia.

Track your weekly SSB servings. If you live in or travel to regions with rapidly rising intake (like Sub-Saharan Africa or parts of Asia), be aware that marketing is aggressively targeting these demographics. Aim to keep added sugars <5-10% of daily calories as recommended by national guidelines.

High-fat diets (>46% calories from fat, <21% from carbs) do not improve exercise performance despite increasing fat oxidation.

Do not follow a high-fat, low-carb diet to improve performance. While it may help your body burn more fat, it does not make you faster and can actually hurt your performance, especially in intense or long events.

Bariatric surgery induces early, pronounced improvements in hepatic and peripheral insulin sensitivity and glycemic control that occur independently of significant weight loss, primarily through anatomical remodeling of the gastrointestinal tract.

If you have severe obesity and type 2 diabetes, bariatric surgery can resolve your diabetes through hormonal changes in your gut, not just by making you smaller. This happens quickly, often before you lose much weight. Consult a multidisciplinary unit to see if you are a candidate.

GLP-1 receptor agonists (specifically liraglutide and dulaglutide) are associated with a statistically significant increase in the risk of overall thyroid disorders compared to placebo or other interventions, although they do not significantly increase the risk of specific conditions like thyroid cancer, hyperthyroidism, or hypothyroidism.

If you are taking a GLP-1 medication like liraglutide or dulaglutide, be aware that there is a slightly higher statistical risk of developing 'overall thyroid disorders' compared to those not taking the drug. However, this does not appear to increase your risk of thyroid cancer or major thyroid dysfunction. Standard monitoring is advised, but the fear of cancer based on animal studies is not supported by large human clinical trials.

Among specific GLP-1 receptor agonists, liraglutide and dulaglutide show a statistically significant increase in the risk of overall thyroid disorders, whereas semaglutide, lixisenatide, and exenatide do not show a significant effect.

Not all GLP-1 medications affect the thyroid equally. If you are concerned about thyroid health, liraglutide and dulaglutide have shown a statistically significant increase in overall thyroid disorders in large trials, whereas semaglutide, lixisenatide, and exenatide have not shown this significant risk. Discuss these differences with your provider when choosing a specific agent.

Tirzepatide requires GIP receptor (GIPR) activation to stimulate insulin secretion in human islets, as blocking GIPR consistently reduces this response.

Tirzepatide's effectiveness in lowering blood sugar relies on its ability to activate the GIP receptor, not just the GLP-1 receptor. In human tissue, blocking the GIP receptor stops tirzepatide from stimulating insulin, proving this second pathway is essential for its full benefit.

Tirzepatide stimulates glucagon secretion in human islets primarily through GIP receptor activation, which overrides the glucagon-suppressing effect of GLP-1 receptor activation.

Tirzepatide increases glucagon secretion via the GIP receptor, which might seem counterintuitive for a diabetes drug. However, this is a normal physiological response to nutrient sensing, and the drug's overall effect is still a significant reduction in blood glucose due to its powerful insulin-stimulating effects.

Tirzepatide stimulates insulin secretion in mouse islets predominantly through the GLP-1 receptor, with minimal GIP receptor contribution at therapeutic doses.

Research on tirzepatide using mice may not fully reflect how it works in humans, as mice require much higher doses for GIP receptor activation. This highlights the importance of human-specific studies for understanding the drug's full mechanism.

Intensive lifestyle intervention does not significantly improve objective physical examination measures of diabetic peripheral neuropathy (such as vibration sense or monofilament light touch) compared to control, except for a slight preservation of light touch sensation when both feet are considered together.

While lifestyle changes improve how patients *feel* (less pain, numbness), they may not always reverse objective nerve damage detectable by standard physical exams like monofilament testing. This highlights the importance of symptom management and prevention of progression, even if structural reversal is not achieved.